Faecal Analyses in Spondyloarthritis Therapy

RecruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
SpondyloarthropathiesAnkylosing Spondylitis
Interventions
DRUG

TNF-inhibition

Initiation of immunosuppression with any TNF-inhibitor, e.g. infliximab, etanercept or adalimumab

Trial Locations (1)

221 85

RECRUITING

Reumatologi SUS Lund, Region Skåne, Lund

All Listed Sponsors
lead

Region Skane

OTHER